Coronavirus digest: India's Covaxin effective against all variants
Published
India's Bharat Biotech says late-stage trials showed Covaxin was 93.4% effective against severe symptomatic COVID. Meanwhile, Australia's New South Wales state reported its biggest daily rise in infections this year.
Full Article